Escalon Medical Corp. reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported revenue was USD 3.43 million compared to USD 2.42 million a year ago. Net income was USD 0.585235 million compared to net loss of USD 0.296016 million a year ago. Basic earnings per share from continuing operations was USD 0.08 compared to basic loss per share from continuing operations of USD 0.04 a year ago. Diluted earnings per share from continuing operations was USD 0.04 compared to diluted loss per share from continuing operations of USD 0.04 a year ago.
For the nine months, revenue was USD 9.04 million compared to USD 7.79 million a year ago. Net income was USD 0.258468 million compared to net loss of USD 0.03195 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to basic loss per share from continuing operations of USD 0.01 a year ago. Diluted earnings per share from continuing operations was USD 0.02 compared to diluted loss per share from continuing operations of USD 0.01 a year ago.